Patents by Inventor Martin Lyndale Windsor

Martin Lyndale Windsor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140308272
    Abstract: According to the present invention, treatment of prion protein related diseases, and in particular cancer tumours, is effected by providing to a subject in need thereof a therapeutically effective amount of an agent capable of modulating binding of a prion protein and/or a prion-like protein to a disease related GAG and/or HSPG.
    Type: Application
    Filed: January 17, 2014
    Publication date: October 16, 2014
    Applicant: Sylvan Pharmaceuticals Pty, Ltd.
    Inventors: John Fergus McEwan, David Cullis-Hill, Martin Lyndale Windsor
  • Publication number: 20110044975
    Abstract: According to the present invention, treatment of prion protein related diseases, and in particular cancer tumours, is effected by providing to a subject in need thereof a therapeutically effective amount of an agent capable of modulating binding of a prion protein and/or a prion-like protein to a disease related GAG and/or HSPG.
    Type: Application
    Filed: August 8, 2008
    Publication date: February 24, 2011
    Inventors: John Fergus McEwan, David Chllis-Hill, Martin Lyndale Windsor